The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials

References

• Merskey H, Bogduk N. Classification of Chronic Pain. In: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms. Seattle: IASP Press, 1994
   Google Scholar
• Sadosky A, McDermott AM, Brandenburg NA, et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8:45-56
   PubMedGoogle Scholar
• Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001;12:447-59
   PubMedGoogle Scholar
• Attal N, Cruccu G, Haanpää M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69
   PubMed Web of Science ®Google Scholar
• Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med 2004;5(Suppl. 1):S28-47
   PubMed Web of Science ®Google Scholar
• Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy 2001;21:1070-81
   PubMed Web of Science ®Google Scholar
• McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75-9
   PubMedGoogle Scholar
• Moote CA, Knill RL, Skinner MI. Morphine disrupts nocturnal sleep in a dose dependent fashion [abstract]. Anesth Analg 1989;68:S200
   Google Scholar
• Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998;14:311-14
   PubMed Web of Science ®Google Scholar
• Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000;23:1-13
   PubMed Web of Science ®Google Scholar
• Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med 2004;5(Suppl. 1):S9-S27
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-85
   PubMed Web of Science ®Google Scholar
• Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007;23:15-22
   PubMed Web of Science ®Google Scholar
• Bazil CW. Effects of antiepileptic drugs on sleep structure: are all drugs equal? CNS Drugs 2003;17:719-28
   PubMed Web of Science ®Google Scholar
• Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med 2003;4:51-5
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Taylor CP, Donevan S, et al. Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007;28:75-82
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18
   PubMed Web of Science ®Google Scholar
• Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007;73:137-50
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent modulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000;295:1086-93
   PubMed Web of Science ®Google Scholar
• Dooley DJ, Mieske CA, Borosky SA. Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000;280:107-10
   PubMed Web of Science ®Google Scholar
• Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003;105:133-41
   PubMed Web of Science ®Google Scholar
• Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002;42:229-36
   PubMed Web of Science ®Google Scholar
• Maneuf YP, Hughes J, McKnight AT. Gabapentin inhibits the substance P-facilitated K+-evoked release of [3H]glutamate from rat caudial trigeminal nucleus slices. Pain 2001;93:191-6
   PubMed Web of Science ®Google Scholar
• Field MJ, Cox PJ, Stott E, et al. Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006;103:17537-42
   PubMed Web of Science ®Google Scholar
• Kubota T, Fang J, Meltzer LT, et al. Pregabalin enhances nonrapid eye movement sleep. J Pharmacol Exp Ther 2001;299:1095-105
   PubMed Web of Science ®Google Scholar
• Lee J, Kim D, Shin HS. Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking α1G-subunit of T-type calcium channels. Proc Natl Acad Sci USA 2004;101:18195-9
   PubMed Web of Science ®Google Scholar
• de Haas S, Otte A, de Weerd A, et al. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. J Clin Sleep Med 2007;3:473-8
   PubMed Web of Science ®Google Scholar
• Russell IJ, Crofford LJ, Leon T, et al. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med 2009;10:604-10
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-83
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254-63
   PubMed Web of Science ®Google Scholar
• Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004;63:2104-10
   PubMed Web of Science ®Google Scholar
• Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-60
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Tuchman M, LaMoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110:628-38
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35
   PubMed Web of Science ®Google Scholar
• Tölle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain 2008;12:203-13
   PubMed Web of Science ®Google Scholar
• van Seventer R, Feister HA, Young JP Jr, et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006;22:375-84
   PubMed Web of Science ®Google Scholar
• Arezzo JC, Rosenstock J, Lamoreaux L, et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 2008;8:33
   PubMed Web of Science ®Google Scholar
• Hays R, Stewart A. Sleep Measures. In: Stewart A, Ware Jr J (eds). Measuring Functioning and Well-being. Durham, NC: The RAND Corporation, 1992:235-59
   Google Scholar
• Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-4
   PubMed Web of Science ®Google Scholar
• Mundel T, Martin S, LaMoreaux L, et al. Polysomnographic evaluation of sleep disturbance in neuropathic pain. Sleep 2003;26 (abstract suppl.):A354
   Google Scholar
• Roehrs T, Roth T. Sleep and pain: interaction of two vital functions. Semin Neurol 2005;25:106-16
   PubMed Web of Science ®Google Scholar
• Buvanendran A, Kroin JS, Della Valle CJ, et al. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg 2010;110:199-207
   PubMed Web of Science ®Google Scholar
• Kurokawa I, Kumano K, Murakawa K. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res 2002;30:56-65
   PubMed Web of Science ®Google Scholar
• Knutson KL. Impact of sleep and sleep loss on glucose homeostasis and appetite regulation. Sleep Med Clin 2007;2:187-97
   PubMedGoogle Scholar
• Knutson KL, Ryden AM, Mander BA, et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006;166:1768-74
   PubMed Web of Science ®Google Scholar
• Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007;11:163-78
   PubMed Web of Science ®Google Scholar
• Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann NY Acad Sci 2008;1129:287-304
   PubMed Web of Science ®Google Scholar
• Tanenberg R. Diabetic peripheral neuropathy: painful or painless. Hosp Physician 2009;45:1-8
   Google Scholar